Haemonetics Corporation (HAE)
NYSE: HAE · Real-Time Price · USD
74.38
-0.24 (-0.32%)
Jul 16, 2025, 4:00 PM - Market closed
Haemonetics Stock Forecast
Stock Price Forecast
The 10 analysts that cover Haemonetics stock have a consensus rating of "Strong Buy" and an average price target of $99, which forecasts a 33.1% increase in the stock price over the next year. The lowest target is $84 and the highest is $116.
Price Target: $99 (+33.1%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Haemonetics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 4 | 5 |
| Buy | 3 | 3 | 3 | 3 | 4 | 4 |
| Hold | 2 | 2 | 2 | 2 | 2 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 9 | 9 | 9 | 10 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barrington Research | Barrington Research | Buy Maintains $95 | Buy | Maintains | $95 | +27.72% | Jul 11, 2025 |
| Citigroup | Citigroup | Hold → Strong Buy Upgrades $71 → $90 | Hold → Strong Buy | Upgrades | $71 → $90 | +21.00% | Jul 9, 2025 |
| Baird | Baird | Buy Initiates $87 | Buy | Initiates | $87 | +16.97% | Jun 26, 2025 |
| JMP Securities | JMP Securities | Buy Reiterates $100 | Buy | Reiterates | $100 | +34.44% | May 20, 2025 |
| Raymond James | Raymond James | Strong Buy Reiterates $115 → $105 | Strong Buy | Reiterates | $115 → $105 | +41.17% | May 9, 2025 |
Financial Forecast
Revenue This Year
1.32B
from 1.36B
Decreased by -2.78%
Revenue Next Year
1.42B
from 1.32B
Increased by 7.26%
EPS This Year
4.91
from 3.31
Increased by 48.48%
EPS Next Year
5.68
from 4.91
Increased by 15.58%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 1.5B | 1.5B | 1.7B |
| Avg | 1.3B | 1.4B | 1.6B |
| Low | 1.3B | 1.3B | 1.5B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 7.5% | 15.3% | 19.5% |
| Avg | -2.8% | 7.3% | 9.9% |
| Low | -7.0% | 2.0% | 4.2% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 5.31 | 6.14 | 6.80 |
| Avg | 4.91 | 5.68 | 6.35 |
| Low | 4.71 | 5.29 | 5.90 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 60.5% | 25.0% | 19.8% |
| Avg | 48.5% | 15.6% | 11.8% |
| Low | 42.3% | 7.7% | 3.9% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.